| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 9, 361-367, Copyright © 1995 by Endocrine Society
ARTICLES |
B Valentinis, A Bhala, T DeAngelis, R Baserga and P Cohen
Department of Pediatrics, University of Pennsylvania, Philadelphia 19104, USA.
The insulin-like growth factors (IGFs) are important mitogens that exert their proliferative effects on cells via the type I IGF receptors (IGF-R). The IGFs also associate with IGF binding proteins (IGFBPs). IGF-inhibitory, IGF-stimulatory, and IGF-independent effects of IGFBPs on cell growth have been reported. We have asked whether the IGFBP-3 has an effect on cell growth, which is independent of its ability to bind IGF-I and thus inhibit the activation of the IGF-I receptor. For this purpose, we have used a fibroblast cell line (R- cells) derived from mouse embryos homozygous for a targeted disruption of the IGF-R gene. When compared with wild type cells (W), which bind IGF-I with high affinity and specificity, R- cells transfected with a mammalian expression vector containing the human (h) IG-FBP-3 cDNA were selected (R-/BP3) and found to express hIGFBP-3 mRNA (detected by Northern blots) and to secrete hIGFBP-3 protein [detected by Western ligand blotting (WLB), immunoblotting, and immunoprecipitation as well as immunofluorescence confocal microscopy]. Growth of five different R- cells, and 10-fold slower compared with W cells, grown under identical conditions. Confluent R- cells. These experiments show that the overexpression of IGFBP-3 has an inhibitory effect on cell growth which does not involve IGF binding to, or signal transduction via, the type I IGF-R. We conclude that the cellular production of IGFBPs serves as a negative regulator of cell proliferation which involves a cellular signaling pathway separate from the IGF-IGF-R system.
This article has been cited by other articles:
![]() |
P. M. Pereira-Fantini, S. L. Thomas, R. G. Taylor, E. Nagy, M. Sourial, P. J. Fuller, and J. E. Bines Colostrum Supplementation Restores Insulin-like Growth Factor -1 Levels and Alters Muscle Morphology Following Massive Small Bowel Resection JPEN J Parenter Enteral Nutr, May 1, 2008; 32(3): 266 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zappala, C. Elbi, J. Edwards, J. Gorenstein, M. M. Rechler, and N. Bhattacharyya Induction of Apoptosis in Human Prostate Cancer Cells by Insulin-Like Growth Factor Binding Protein-3 Does Not Require Binding to Retinoid X Receptor-{alpha} Endocrinology, April 1, 2008; 149(4): 1802 - 1812. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Harris, R. D. Burk, H. Yu, H. Minkoff, L. S. Massad, D. H. Watts, Y. Zhong, S. Gange, R. C. Kaplan, K. Anastos, et al. Insulin-Like Growth Factor Axis and Oncogenic Human Papillomavirus Natural History Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 245 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Kim, Y. B. Seu, S.-H. Baek, M. J. Kim, K. J. Kim, J. H. Kim, and J.-R. Kim Induction of Cellular Senescence by Insulin-like Growth Factor Binding Protein-5 through a p53-dependent Mechanism Mol. Biol. Cell, November 1, 2007; 18(11): 4543 - 4552. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Cobb, B. Liu, K.-W. Lee, and P. Cohen Phosphorylation by DNA-Dependent Protein Kinase Is Critical for Apoptosis Induction by Insulin-Like Growth Factor Binding Protein-3. Cancer Res., November 15, 2006; 66(22): 10878 - 10884. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Peng, P. J. Malloy, J. Wang, and D. Feldman Growth Inhibitory Concentrations of Androgens Up-Regulate Insulin-Like Growth Factor Binding Protein-3 Expression via an Androgen Response Element in LNCaP Human Prostate Cancer Cells Endocrinology, October 1, 2006; 147(10): 4599 - 4607. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bhattacharyya, K. Pechhold, H. Shahjee, G. Zappala, C. Elbi, B. Raaka, M. Wiench, J. Hong, and M. M. Rechler Nonsecreted Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) Can Induce Apoptosis in Human Prostate Cancer Cells by IGF-independent Mechanisms without Being Concentrated in the Nucleus J. Biol. Chem., August 25, 2006; 281(34): 24588 - 24601. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Severi, H. A. Morris, R. J. MacInnis, D. R. English, W. D. Tilley, J. L. Hopper, P. Boyle, and G. G. Giles Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1137 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cohen Insulin-like growth factor binding protein-3: insulin-like growth factor independence comes of age. Endocrinology, May 1, 2006; 147(5): 2109 - 2111. [Full Text] [PDF] |
||||
![]() |
A M M Haydon, R J MacInnis, D R English, H Morris, and G G Giles Physical activity, insulin-like growth factor 1, insulin-like growth factor binding protein 3, and survival from colorectal cancer Gut, May 1, 2006; 55(5): 689 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Santer, N. Bacher, B. Moser, D. Morandell, S. Ressler, S. M. Firth, G. A. Spoden, C. Sergi, R. C. Baxter, P. Jansen-Durr, et al. Nuclear insulin-like growth factor binding protein-3 induces apoptosis and is targeted to ubiquitin/proteasome-dependent proteolysis. Cancer Res., March 15, 2006; 66(6): 3024 - 3033. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Lee, M. Takahashi, K. Honke, E. Miyoshi, D. Osumi, H. Sakiyama, A. Ekuni, X. Wang, S. Inoue, J. Gu, et al. Loss of core fucosylation of low-density lipoprotein receptor-related protein-1 impairs its function, leading to the upregulation of serum levels of insulin-like growth factor-binding protein 3 in fut8-/- mice. J. Biochem., March 1, 2006; 139(3): 391 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Oh, W.-Y. Kim, J.-H. Kim, M. N. Younes, A. K. El-Naggar, J. N. Myers, M. Kies, P. Cohen, F. Khuri, W. K. Hong, et al. Identification of Insulin-Like Growth Factor Binding Protein-3 as a Farnesyl Transferase Inhibitor SCH66336-Induced Negative Regulator of Angiogenesis in Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., January 15, 2006; 12(2): 653 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Belizon, I. Kirman, M. Karten, S. Jain, and R. L. Whelan Rapid Increase in Serum Levels of Matrix Metalloproteinase-9 (MMP-9) Postoperatively is Associated With a Decrease in the Amount of Intracellular MMP-9 Surgical Innovation, December 1, 2005; 12(4): 333 - 337. [Abstract] [PDF] |
||||
![]() |
S. S. Y. Chan, S. M. Twigg, S. M. Firth, and R. C. Baxter Insulin-Like Growth Factor Binding Protein-3 Leads to Insulin Resistance in Adipocytes J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6588 - 6595. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Grohmann, E. Foulstone, G. Welsh, J. Holly, J. Shield, E. Crowne, and C. Stewart Isolation and validation of human prepubertal skeletal muscle cells: maturation and metabolic effects of IGF-I, IGFBP-3 and TNF{alpha} J. Physiol., October 1, 2005; 568(1): 229 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. F. Lu, X. G. Jiang, Y. B. Lu, J. H. Bai, and Z. B. Mao Characterization of a Novel Positive Transcription Regulatory Element That Differentially Regulates the Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) Gene in Senescent Cells J. Biol. Chem., June 17, 2005; 280(24): 22606 - 22615. [Abstract] [Full Text] [PDF] |
||||
![]() |
L O'Rear, L Longobardi, M Torello, B K Law, H L Moses, F Chiarelli, and A Spagnoli Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-{beta} in mesenchymal chondroprogenitor cell growth J. Mol. Endocrinol., June 1, 2005; 34(3): 723 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hayashi, K. D Carpenter, T. H Welsh Jr, R. C Burghardt, L. J Spicer, and T. E Spencer The IGF system in the neonatal ovine uterus Reproduction, March 1, 2005; 129(3): 337 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Silha, Y. Gui, S. Mishra, A. Leckstrom, P. Cohen, and L. J. Murphy Overexpression of Gly56/Gly80/Gly81-Mutant Insulin-Like Growth Factor-Binding Protein-3 in Transgenic Mice Endocrinology, March 1, 2005; 146(3): 1523 - 1531. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, J. Xiang, and C. Duan Insulin-like Growth Factor-binding Protein-3 Plays an Important Role in Regulating Pharyngeal Skeleton and Inner Ear Formation and Differentiation J. Biol. Chem., February 4, 2005; 280(5): 3613 - 3620. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Cobb, D. A. M. Salih, I. Gonzalez, G. Tripathi, E. J. Carter, F. Lovett, C. Holding, and J. M. Pell Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function J. Cell Sci., May 1, 2004; 117(9): 1737 - 1746. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Ongeri, Q. Zhu, M. F. Verderame, and J. M. Hammond Insulin-Like Growth Factor-Binding Protein-3 in Porcine Ovarian Granulosa Cells: Gene Cloning, Promoter Mapping, and Follicle-Stimulating Hormone Regulation Endocrinology, April 1, 2004; 145(4): 1776 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. M. Salih, G. Tripathi, C. Holding, T. A. M. Szestak, M. I. Gonzalez, E. J. Carter, L. J. Cobb, J. E. Eisemann, and J. M. Pell Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice PNAS, March 23, 2004; 101(12): 4314 - 4319. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Kim, A. R. Ingermann, J. Tsubaki, S. M. Twigg, G. E. Walker, and Y. Oh Insulin-Like Growth Factor-Binding Protein 3 Induces Caspase-Dependent Apoptosis through a Death Receptor-Mediated Pathway in MCF-7 Human Breast Cancer Cells Cancer Res., March 15, 2004; 64(6): 2229 - 2237. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Colao, D. Ferone, P. Marzullo, and G. Lombardi Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management Endocr. Rev., February 1, 2004; 25(1): 102 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Mikheev, S. A. Mikheeva, B. Liu, P. Cohen, and H. Zarbl A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation Carcinogenesis, January 1, 2004; 25(1): 47 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Edmondson, S. P. Thumiger, G. A. Werther, and C. J. Wraight Epidermal Homeostasis: The Role of the Growth Hormone and Insulin-Like Growth Factor Systems Endocr. Rev., December 1, 2003; 24(6): 737 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Longobardi, M. Torello, C. Buckway, L. O'Rear, W. A. Horton, V. Hwa, C. T. Roberts Jr., F. Chiarelli, R. G. Rosenfeld, and A. Spagnoli A Novel Insulin-Like Growth Factor (IGF)-Independent Role for IGF Binding Protein-3 in Mesenchymal Chondroprogenitor Cell Apoptosis Endocrinology, May 1, 2003; 144(5): 1695 - 1702. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Schedlich, T. Nilsen, A. P. John, D. A. Jans, and R. C. Baxter Phosphorylation of Insulin-Like Growth Factor Binding Protein-3 by Deoxyribonucleic Acid-Dependent Protein Kinase Reduces Ligand Binding and Enhances Nuclear Accumulation Endocrinology, May 1, 2003; 144(5): 1984 - 1993. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.J. Collard, M. Guy, A.J. Butt, C.M. Perks, J.M.P. Holly, C. Paraskeva, and A.C. Williams Transcriptional upregulation of the insulin-like growth factor binding protein IGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma-derived epithelial cells Carcinogenesis, March 1, 2003; 24(3): 393 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Franklin, R. J. Ferry Jr., and P. Cohen Rapid Insulin-Like Growth Factor (IGF)-Independent Effects of IGF Binding Protein-3 on Endothelial Cell Survival J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 900 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Spoerri, S. Caballero, S. H. Wilson, L. C. Shaw, and M. B. Grant Expression of IGFBP-3 by Human Retinal Endothelial Cell Cultures: IGFBP-3 Involvement in Growth Inhibition and Apoptosis Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 365 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Firth and R. C. Baxter Cellular Actions of the Insulin-Like Growth Factor Binding Proteins Endocr. Rev., December 1, 2002; 23(6): 824 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cordain, S. Lindeberg, M. Hurtado, K. Hill, S. B. Eaton, and J. Brand-Miller Acne Vulgaris: A Disease of Western Civilization Arch Dermatol, December 1, 2002; 138(12): 1584 - 1590. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. McCaig, C. M. Perks, and J. M. P. Holly Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin J. Cell Sci., November 15, 2002; 115(22): 4293 - 4303. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Silha, Y. Gui, and L. J. Murphy Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E937 - E945. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Ricort and M. Binoux Insulin-like Growth Factor-binding Protein-3 Activates a Phosphotyrosine Phosphatase. EFFECTS ON THE INSULIN-LIKE GROWTH FACTOR SIGNALING PATHWAY J. Biol. Chem., May 24, 2002; 277(22): 19448 - 19454. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Spagnoli, M. Torello, S. R. Nagalla, W. A. Horton, P. Pattee, V. Hwa, F. Chiarelli, C. T. Roberts Jr., and R. G. Rosenfeld Identification of STAT-1 as a Molecular Target of IGFBP-3 in the Process of Chondrogenesis J. Biol. Chem., May 17, 2002; 277(21): 18860 - 18867. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rajah, K.-W. Lee, and P. Cohen Insulin-like Growth Factor Binding Protein-3 Mediates Tumor Necrosis Factor-{alpha}-induced Apoptosis: Role of Bcl-2 Phosphorylation Cell Growth Differ., April 1, 2002; 13(4): 163 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hong, G. Zhang, F. Dong, and M. M. Rechler Insulin-like Growth Factor (IGF)-binding Protein-3 Mutants That Do Not Bind IGF-I or IGF-II Stimulate Apoptosis in Human Prostate Cancer Cells J. Biol. Chem., March 15, 2002; 277(12): 10489 - 10497. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Buckway, E. M. Wilson, M. Ahlsen, P. Bang, Y. Oh, and R. G. Rosenfeld Mutation of Three Critical Amino Acids of the N-Terminal Domain of IGF-Binding Protein-3 Essential for High Affinity IGF Binding J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4943 - 4950. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Chan, M. Pollak, and H. Huynh Inhibition of Insulin-like Growth Factor Signaling Pathways in Mammary Gland by Pure Antiestrogen ICI 182,780 Clin. Cancer Res., August 1, 2001; 7(8): 2545 - 2554. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Gleeson, C. Chakraborty, T. McKinnon, and P. K. Lala Insulin-Like Growth Factor-Binding Protein 1 Stimulates Human Trophoblast Migration by Signaling through {{alpha}}5{beta}1 Integrin via Mitogen-Activated Protein Kinase Pathway J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2484 - 2493. [Abstract] [Full Text] [PDF] |
||||
![]() |
R C Baxter Signalling pathways involved in antiproliferative effects of IGFBP-3: a review Mol. Pathol., June 1, 2001; 54(3): 145 - 148. [Abstract] [Full Text] |
||||
![]() |
T. Modric, J. V. Silha, Z. Shi, Y. Gui, A. Suwanichkul, S. K. Durham, D. R. Powell, and L. J. Murphy Phenotypic Manifestations of Insulin-Like Growth Factor-Binding Protein-3 Overexpression in Transgenic Mice Endocrinology, May 1, 2001; 142(5): 1958 - 1967. [Abstract] [Full Text] |
||||
![]() |
S. A. Weinzimer, T. B. Gibson, P. F. Collett-Solberg, A. Khare, B. Liu, and P. Cohen Transferrin Is an Insulin-Like Growth Factor-Binding Protein-3 Binding Protein J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1806 - 1813. [Abstract] [Full Text] |
||||
![]() |
J. Khosravi, A. Diamandi, J. Mistry, and A. Scorilas Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein-3 in Benign Prostatic Hyperplasia and Prostate Cancer J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 694 - 699. [Abstract] [Full Text] |
||||
![]() |
J.-M. Ricort and M. Binoux Insulin-Like Growth Factor (IGF) Binding Protein-3 Inhibits Type 1 IGF Receptor Activation Independently of Its IGF Binding Affinity Endocrinology, January 1, 2001; 142(1): 108 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Devi, D.-H. Yang, R. G. Rosenfeld, and Y. Oh Differential Effects of Insulin-Like Growth Factor (IGF)-Binding Protein-3 and Its Proteolytic Fragments on Ligand Binding, Cell Surface Association, and IGF-I Receptor Signaling Endocrinology, November 1, 2000; 141(11): 4171 - 4179. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Mannhardt, S. A. Weinzimer, M. Wagner, M. Fiedler, P. Cohen, P. Jansen-Dürr, and W. Zwerschke Human Papillomavirus Type 16 E7 Oncoprotein Binds and Inactivates Growth-Inhibitory Insulin-Like Growth Factor Binding Protein 3 Mol. Cell. Biol., September 1, 2000; 20(17): 6483 - 6495. [Abstract] [Full Text] |
||||
![]() |
A. Diamandi, J. Mistry, R. G. Krishna, and J. Khosravi Immunoassay of Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3): New Means to Quantifying IGFBP-3 Proteolysis J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2327 - 2333. [Abstract] [Full Text] |
||||
![]() |
R. C. Baxter Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E967 - E976. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Herrler, J. M. Pell, W.R. Allen, H.M. Beier, and F. Stewart Horse Conceptuses Secrete Insulin-Like Growth Factor-Binding Protein 3 Biol Reprod, June 1, 2000; 62(6): 1804 - 1811. [Abstract] [Full Text] |
||||
![]() |
P. Cohen, R. Rajah, J. Rosenbloom, and D. J. Herrick IGFBP-3 mediates TGF-beta 1-induced cell growth in human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, March 1, 2000; 278(3): L545 - L551. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Coverley, J. L. Martin, and R. C. Baxter The Effect of Phosphorylation by Casein Kinase 2 on the Activity of Insulin-Like Growth Factor-Binding Protein-3 Endocrinology, February 1, 2000; 141(2): 564 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Kritsch, D. J. Huss, and D. M. Ney Greater potency of IGF-I than IGF-I/BP-3 complex in catabolic parenterally fed rats Am J Physiol Endocrinol Metab, February 1, 2000; 278(2): E252 - E262. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Sprenger, S. E. Damon, V. Hwa, R. G. Rosenfeld, and S. R. Plymate Insulin-like Growth Factor Binding Protein-related Protein 1 (IGFBP-rP1) Is a Potential Tumor Suppressor Protein for Prostate Cancer Cancer Res., May 1, 1999; 59(10): 2370 - 2375. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Burroughs, S. E. Dunn, J. C. Barrett, and J. A. Taylor Insulin-Like Growth Factor-I: a Key Regulator of Human Cancer Risk? J Natl Cancer Inst, April 7, 1999; 91(7): 579 - 581. [Full Text] [PDF] |
||||
![]() |
S. M. Leal, S. S. Huang, and J. S. Huang Interactions of High Affinity Insulin-like Growth Factor-binding Proteins with the Type V Transforming Growth Factor-beta Receptor in Mink Lung Epithelial Cells J. Biol. Chem., March 5, 1999; 274(10): 6711 - 6717. [Abstract] [Full Text] [PDF] |
||||